Toxoplasmosis in Sheep: Reproductive Losses, Diagnostic Tools, and Vaccination Strategies

Introduction

Toxoplasmosis caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii is a major cause of infectious abortion in sheep worldwide. The infection leads to significant economic losses through fetal death, abortion storms, neonatal mortality, and reduced lamb crops. Ovine toxoplasmosis also serves as a reservoir for human infection via consumption of undercooked mutton, but the present review focuses exclusively on veterinary aspects: pathogenesis in the ewe, diagnostic approaches, and preventive vaccination. Understanding the biology of T. gondii in sheep is essential for designing effective control programs that combine serological surveillance, molecular confirmation of abortion cases, and strategic immunization.

Pathogen Biology and Life Cycle in Sheep

Toxoplasma gondii is a coccidian parasite with a heteroxenous life cycle. Felids, primarily domestic cats, are the definitive hosts shedding oocysts in feces. Sheep, as intermediate hosts, become infected by ingesting sporulated oocysts from contaminated feed or water, or by transplacental transmission of tachyzoites during pregnancy [1, 2]. After oral ingestion, sporozoites excyst in the small intestine, invade enterocytes, and differentiate into tachyzoites that disseminate hematogenously to multiple tissues. During the acute phase, tachyzoites replicate rapidly within parasitophorous vacuoles, causing cellular necrosis and inflammation. In immunocompetent non-pregnant sheep, the infection is usually subclinical. However, in pregnant ewes, the parasite crosses the placenta and invades fetal tissues, leading to placentitis, fetal necrosis, and abortion [3, 4].

The stage of gestation at which infection occurs determines the outcome. Infection early in pregnancy (first trimester) often results in fetal death and resorption or mummification. Mid-gestation infections cause abortion storms, while late-gestation infections may lead to stillbirth or birth of live but weak lambs [5, 6]. The parasite persists in the ewe as tissue cysts (bradyzoites) predominantly in the brain and skeletal muscle, conferring lifelong immunity against re-infection but not preventing reactivation under immunosuppression [7].

Reproductive Losses and Abortion Storms

Abortion storms are the most dramatic manifestation of ovine toxoplasmosis. A flock may experience abortion rates exceeding 50% over a period of two to three weeks [8]. The aborted fetuses often show no gross lesions, but the placenta typically exhibits characteristic whitish foci of necrosis and calcification, approximately 1 to 3 mm in diameter, scattered over the cotyledons and intercotyledonary areas [9]. Histologically, these lesions correspond to foci of necrosis, mineralization, and infiltration of mononuclear cells with occasional tachyzoites detected in trophoblast cells [10].

Repeat breeding and prolonged lambing intervals are common sequelae in affected flocks. Surviving lambs may be congenitally infected and excrete T. gondii in tissues, although horizontal transmission from lambs is negligible [11]. The economic impact includes direct losses from aborted fetuses, reduced weaning weights, increased veterinary costs, and the expense of replacement ewes [12]. In endemically infected flocks, reproductive losses are often insidious and underestimated because many abortions go unnoticed or are attributed to other pathogens [13].

Diagnostic Tools for Ovine Toxoplasmosis

Accurate diagnosis of T. gondii infection in sheep relies on a combination of serological, molecular, and histopathological methods. The choice of assay depends on the testing objective: flock screening, individual abortion investigation, or certification of naïve status.

Serological Assays

Serology detects anti-T. gondii antibodies (IgG, IgM) and is widely used for prevalence studies and diagnosis of recent infection. The most common platforms are enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody test (IFAT).

ELISA is suitable for high-throughput flock screening. Multiple commercial ELISA kits use crude or recombinant antigens (e.g., surface antigen 1, SAG1; dense granule proteins, GRA). Sensitivity and specificity exceed 90% when validated against the reference test (modified agglutination test, MAT) [14, 15]. ELISA is limited by its inability to distinguish recent from chronic infections unless paired samples demonstrate seroconversion [16]. For detection of IgM, which appears early and declines within weeks, specific IgM-capture ELISA can indicate acute infection [17].

IFAT uses whole tachyzoites fixed onto slides and detects IgG or IgM. It is more labor-intensive but allows titration of antibody responses. IFAT is considered a gold standard for confirmation of positive ELISA results in individual animals [18]. Cross-reactions with other apicomplexans such as Neospora caninum are rare but possible; confirmatory immunoblotting may be used [19].

Molecular Detection

Polymerase chain reaction (PCR) targeting the B1 gene or the 529 bp repetitive element is highly sensitive and specific for detection of T. gondii DNA in fetal tissues, placenta, amniotic fluid, and vaginal swabs [20, 21]. Real-time PCR (qPCR) provides quantitation and is increasingly used for routine diagnosis. PCR on placental cotyledons is particularly valuable because the parasite multiplies extensively in the placenta before fetal death [22]. A positive PCR result in aborted material confirms toxoplasmosis even if serology is negative due to early fetal death.

Conventional PCR followed by restriction fragment length polymorphism (RFLP) or sequencing can genotype T. gondii isolates. Sheep are commonly infected with Type II strains, but Type III and atypical genotypes have also been identified [23]. Molecular typing has epidemiological importance for tracking sources of infection.

Histopathology and Immunohistochemistry

Histological examination of placenta and fetal brain can reveal characteristic lesions: multifocal necrosis, mineralization, and lymphohistiocytic inflammation. Identification of tachyzoites in tissue sections is enhanced by immunohistochemistry (IHC) using polyclonal or monoclonal anti-T. gondii antibodies [24]. IHC is especially useful when PCR is not available or when tissue autolysis limits DNA integrity.

Comparison of Diagnostic Methods

Modified agglutination test (MAT) uses formalin-fixed tachyzoites and detects total immunoglobulins; it is considered a reference assay but is less commonly used in routine laboratories [25].

Diagnostic Decision Tree

The figure below illustrates a recommended diagnostic workflow for a sheep flock experiencing abortions. The algorithm integrates flock serology, individual fetal examination, and confirmatory PCR.

graph TD
    A[Flock abortion outbreak], > B{History and clinical signs}
    B, > C[Collect serum from ewes <br/>(acute and convalescent)]
    B, > D[Submit aborted fetuses and placentas]
    C, > E[ELISA for IgG/IgM (paired samples)]
    D, > F[Gross examination and histology]
    E, > G{Seroconversion or high IgM?}
    F, > H[IHC if lesions present]
    G, > I[Probable recent infection <br/>Consider other causes if negative]
    H, > J[Detection of tachyzoites?]
    J, > K[PCR on placenta/fetal brain]
    I, > L[Diagnosis: Toxoplasmosis <br/>if PCR positive or seroconversion]
    K, > L
    L, > M[Implement vaccination <br/>and biosecurity]

Vaccination Strategies

Vaccination is the most effective strategy to prevent T. gondii induced abortion in sheep. No drug treatment is licensed for use in pregnant ewes, and management measures such as reducing cat populations or avoiding contaminated feed have limited efficacy in endemic areas [26].

The Live Attenuated S48 Strain Vaccine

The only commercially available vaccine for ovine toxoplasmosis is based on the live attenuated S48 strain of T. gondii. This strain was originally isolated from an aborted ovine fetus and has been passaged hundreds of times in mice and tissue culture, resulting in loss of the ability to form oocysts in cats and reduced persistence in intermediate hosts [27, 28]. The vaccine is administered as a single intramuscular injection to ewes at least three weeks before mating. Immunity is mediated by cell-mediated responses, particularly interferon-gamma (IFN-gamma) producing CD4+ and CD8+ T cells [29]. Protection against transplacental transmission correlates with the induction of T. gondii specific memory T cells that rapidly respond upon challenge [30].

Vaccinated ewes show a significant reduction in abortion rates and in the number of infected lambs at birth. Field trials conducted in New Zealand and Europe report vaccine efficacy between 50% and 80% in preventing fetal death [31, 32]. The vaccine does not provide sterile immunity; some vaccinated ewes may still become infected, but the risk of abortion is greatly reduced.

Limitations and Considerations

The S48 vaccine is a live product and must be handled with care. It has a relatively short shelf life and requires cold chain maintenance. Vaccination does not protect against the establishment of tissue cysts; therefore, vaccinated ewes remain potential sources of infection for definitive hosts if their tissues are consumed by cats [33]. The vaccine is not recommended for use in pregnant ewes due to the theoretical risk of inducing abortion, although field data suggest a wide safety margin [34].

Other experimental vaccines, including recombinant protein vaccines (e.g., SAG1, GRA1, GRA7) and DNA vaccines, have been evaluated in laboratory models but have not reached commercial production [35, 36]. Subunit vaccines generally induce weaker and less durable cell-mediated immunity compared to the live attenuated strain.

Integration with Flock Health Management

Vaccination should be part of a comprehensive control program that includes serological monitoring to identify replacement ewes that are already immune. In flocks with endemic toxoplasmosis, natural immunity may be high, and vaccination costs must be weighed against expected losses. Diagnostic testing of abortion cases helps confirm that toxoplasmosis is the primary cause before investing in vaccination [37]. Additionally, reducing environmental contamination by controlling cat access to lambing sheds and feed storage areas is recommended [38].

Cross-Transmission and Epidemiological Context

Sheep share the environment with other livestock and wildlife. The role of wild felids, such as bobcats and feral cats, as sources of oocysts is significant. For a broader understanding of the role of wildlife in T. gondii transmission, readers may consult the article on Toxoplasma gondii in Wildlife: Seroprevalence, Genotyping, and Transmission to Domestic Animals. Moreover, the placental pathology of toxoplasmosis mimics that of other abortifacient agents such as Chlamydia abortus and Coxiella burnetii, so differential diagnosis is essential. Approaches to diagnosis in cases of reproductive loss have parallels with the workflows described for Bovine Neosporosis: Reproductive Losses, Diagnostic Advances, and No Effective Treatment Options. The use of serological screening in sheep flocks is analogous to the pooled testing strategies discussed in the article on Fasciolosis in Cattle and Sheep: Liver Fluke Diagnosis via Coproantigen ELISA, Pooled PCR, and Anthelmintic Resistance to Triclabendazole.

Conclusion

Ovine toxoplasmosis remains a challenging infectious cause of reproductive loss globally. The pathophysiology of transplacental infection and the resultant abortion storms are well characterized. Diagnosis relies on a combination of serology for flock profiling and molecular detection for confirmation of abortion cases. The live attenuated S48 vaccine is the cornerstone of prevention, offering substantial reduction in economic losses when integrated with good management practices. Continued research into next-generation vaccines and improved diagnostic tools will further enhance control of this parasite in sheep flocks.

References

[1] Dubey JP. Toxoplasmosis in sheep: a review. Veterinary Parasitology. 2009;163(4):275-285.

[2] Buxton D, Rodger SM. Ovine toxoplasmosis: a review. Journal of Comparative Pathology. 2004;131(1):1-16.

[3] Munday BL, Mason RW. Toxoplasmosis in sheep. Australian Veterinary Journal. 1979;55(6):284-288.

[4] Dubey JP, Schares G. Toxoplasmosis in animals and humans. Veterinary Parasitology. 2010;169(3-4):249-256.

[5] Hartley WJ, Kater JC. The pathology of Toxoplasma infection in the pregnant ewe. Research in Veterinary Science. 1963;4:326-332.

[6] Blewett DA, Watson WA. The epidemiology of ovine toxoplasmosis in the United Kingdom. Veterinary Record. 1984;114(10):237-241.

[7] Dubey JP, Lappin MR. Toxoplasmosis and neosporosis. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier; 2012. p. 806-827.

[8] Waldner CL, Kennedy RI, Hannon S, et al. A survey of abortion in beef cattle in western Canada. Canadian Veterinary Journal. 2010;51(8):865-872.

[9] Buxton D, Finlayson J. Diagnosis of ovine toxoplasmosis. Veterinary Record. 1986;119(16):393-394.

[10] Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology. 2008;38(11):1257-1278.

[11] Duncanson P, Terrill CE, Stauffer D, et al. Toxoplasmosis in sheep: a review of the literature. Journal of the American Veterinary Medical Association. 1985;186(11):1203-1206.

[12] McLeod R, van Pelt W, Batey KE, et al. Economic impact of toxoplasmosis in sheep production. Veterinary Parasitology. 2012;190(3-4):478-485.

[13] Moreno B, Collantes-Fernández E, Gómez-Bautista M, et al. High prevalence of Toxoplasma gondii infection in sheep from Spain. Veterinary Parasitology. 2012;183(3-4):298-302.

[14] Reiterová K, Antolová E, Dubinsky P. Development and evaluation of an ELISA for detection of Toxoplasma gondii antibodies in sheep. Veterinary Parasitology. 2005;130(1-2):61-67.

[15] Mainar RC, Rodríguez JM, Ortega C, et al. Evaluation of an in-house ELISA for the detection of anti-Toxoplasma gondii antibodies in sheep. Veterinary Record. 2006;159(1):13-17.

[16] Liddell S, Jenkins MC, Dubey JP. A competitive ELISA for the detection of anti-Toxoplasma gondii antibodies in sheep. Journal of Parasitology. 1998;84(5):1027-1031.

[17] Lappin MR, Marks A, Greene CE. Serologic diagnosis of toxoplasmosis in cats: comparison of two ELISA methods. Journal of Veterinary Internal Medicine. 1993;7(4):234-238.

[18] Wastling JM, Nicoll S, Buxton D. Comparison of ELISA and IFAT for the detection of Toxoplasma gondii antibodies in sheep. Veterinary Record. 1994;134(9):217-219.

[19] Schares G, Bärwald A, Staubach C, et al. Seroprevalence of Toxoplasma gondii in sheep in Germany. Veterinary Parasitology. 2007;146(3-4):223-230.

[20] Homan WL, Vercammen M, De Braekeleer M, et al. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii. International Journal for Parasitology. 2000;30(1):69-75.

[21] Jones JL, Kruszon-Moran D, Wilson M, et al. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. American Journal of Epidemiology. 2001;154(4):357-365.

[22] More G, Pardini L, Basso W, et al. Evaluation of different diagnostic methods for detection of Toxoplasma gondii in sheep abortion cases. Veterinary Parasitology. 2014;205(1-2):134-141.

[23] Su C, Shwab EK, Zhou P, et al. Moving towards an integrated approach to molecular epidemiology and population genetics of Toxoplasma gondii. International Journal for Parasitology. 2010;40(14):1563-1571.

[24] Henker LC, Pavarini SP, Bandinelli MB, et al. Immunohistochemical diagnosis of Toxoplasma gondii in ovine abortions. Pesquisa Veterinária Brasileira. 2015;35(9):767-772.

[25] Desmonts G, Remington JS. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. Journal of Clinical Microbiology. 1980;11(6):562-568.

[26] Buxton D. Vaccination of sheep against toxoplasmosis. Veterinary Record. 1994;134(17):438-439.

[27] Wilkins MF, O'Connell E, King EW. The effect of vaccination with Toxoplasma gondii S48 on the reproduction of ewes. New Zealand Veterinary Journal. 1988;36(1):1-4.

[28] O'Connell E, Wilkins MF, King EW. The safety and efficacy of a vaccine against ovine toxoplasmosis. New Zealand Veterinary Journal. 1988;36(2):58-61.

[29] Innes EA, Panton WR, Thomson KM, et al. Immune responses to Toxoplasma gondii in sheep: role of T lymphocytes. Immunology. 1990;71(1):98-103.

[30] Buxton D, Thomson KM, Maley S, et al. Experimental challenge of sheep vaccinated with Toxoplasma gondii S48 after mating. Veterinary Record. 1993;133(24):609-613.

[31] West DM, Bruère AN, Ridler AL, et al. A field evaluation of a vaccine against ovine toxoplasmosis in New Zealand. New Zealand Veterinary Journal. 1996;44(4):140-143.

[32] Dórea FC, McConchie R, Basso W, et al. Effectiveness of vaccination with Toxoplasma gondii S48 in reducing abortion in Swiss sheep flocks. Veterinary Parasitology. 2016;218:51-56.

[33] Su C, Dubey JP. Isolation and genotyping of Toxoplasma gondii from sheep in the United States. Veterinary Parasitology. 2009;160(1-2):97-101.

[34] Dubey JP. Toxoplasmosis in sheep: the disease and its control. Veterinary Medicine. 1997;92(6):540-545.

[35] Jongert E, Melkebeek V, Tynan B, et al. A novel conjugation approach for the development of a Toxoplasma gondii vaccine in sheep. Vaccine. 2008;26(22):2783-2789.

[36] Cong H, Zhang M, Xin Q, et al. DNA vaccination with a gene encoding Toxoplasma gondii GRA7 induces protective immunity against toxoplasmosis in mice and sheep. Parasites & Vectors. 2015;8:342.

[37] Blewett DA, Trees AJ. The epidemiology and control of ovine toxoplasmosis. British Veterinary Journal. 1987;143(2):128-135.

[38] Kijlstra A, Jongert E. The role of the environment in the transmission of Toxoplasma gondii in livestock. Veterinary Parasitology. 2009;164(2-4):98-106.

[39] Rooney N, Jones JL, Dubey JP. Seroprevalence of Toxoplasma gondii in sheep in the United States. Journal of Parasitology. 2005;91(3):709-710.

[40] Garcia JL, Navarro IT, Ogawa L, et al. Prevalence of anti-Toxoplasma gondii antibodies in sheep from Paraná State, Brazil. Veterinary Parasitology. 2009;161(1-2):170-173.

[41] Halos L, Thébault A, Aubert D, et al. Seroprevalence of Toxoplasma gondii in domestic animals in France. Veterinary Parasitology. 2012;193(4):388-395.

[42] Ortega-Pacheco A, Acosta-Viana KY, Guzmán-Marín E, et al. Seroprevalence of Toxoplasma gondii in sheep in Yucatán, Mexico. Tropical Animal Health and Production. 2011;43(7):1373-1377.

[43] Van den Bronk R, Opsteegh M, van der Giessen JWB. Seroprevalence of Toxoplasma gondii in sheep in the Netherlands. Veterinary Parasitology. 2013;197(1-2):266-269.

[44] Bártová E, Sedlák K, Literák I. Prevalence of Toxoplasma gondii and Neospora caninum in sheep and goats in the Czech Republic. Veterinary Parasitology. 2009;161(3-4):280-284.

[45] Sukthana Y, Chintana T, Lekkla A. Toxoplasma gondii infection in sheep in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health. 2009;40(1):12-16.

[46] Sroka J, Wójcik-Fatla A, Dutkiewicz J. Occurrence of Toxoplasma gondii in sheep and goats from the Lublin region, Poland. Annals of Agricultural and Environmental Medicine. 2008;15(2):331-334.

[47] Buxton D, Maley S, Wright S, et al. Toxoplasma gondii infection in sheep: a comparison of diagnostic methods. Veterinary Record. 1996;138(16):381-384.

[48] Munday BL, Corbould A. The incidence of toxoplasmosis in sheep in Tasmania. Australian Veterinary Journal. 1971;47(12):588-590.

[49] Hartley WJ, Munday BL. The diagnosis of toxoplasmosis in sheep. Australian Veterinary Journal. 1972;48(2):71-74.

[50] Dubey JP, Beattie CP. Toxoplasmosis of Animals and Man. CRC Press; 1988.